Neuroprotection via RNA-binding protein RBM3 expression is regulated by hypothermia but not by hypoxia in human SK-N-SH neurons
Open Access
- 1 May 2017
- journal article
- research article
- Published by Taylor & Francis in Hypoxia
- Vol. ume 5, 33-43
Abstract
Objective: Therapeutic hypothermia is an established treatment for perinatal asphyxia. Yet, many term infants continue to die or suffer from neurodevelopmental disability. Several experimental studies have demonstrated a beneficial effect of mild-to-moderate hypothermia after hypoxic injury, but the understanding of hypothermia-induced neuroprotection remains incomplete. In general, global protein synthesis is attenuated by hypothermia, but a small group of RNA-binding proteins including the RNA-binding motif 3 (RBM3) is upregulated in response to cooling. The aim of this study was to establish an in vitro model to investigate the effects of hypoxia and hypothermia on neuronal cell survival, as well as to examine the kinetics of concurrent cold-shock protein RBM3 gene expression. Methods: Experiments were performed by using human SK-N-SH neurons exposed to different oxygen concentrations (21%, 8%, or 0.2% O2) for 24 hours followed by moderate hypothermia (33.5°C) or normothermia for 24, 48, or 72 hours. Cell death was determined by quantification of lactate dehydrogenase and neuron-specific enolase releases into the cell cultured medium, and cell morphology was assessed by using immunofluorescence staining. The regulation of RBM3 gene expression was assessed by reverse transcriptase-quantitative polymerase chain reaction and Western blot analysis. Results: Exposure to hypoxia (0.2% O2) for 24 hours resulted in significantly increased cell death in SK-N-SH neurons, whereas exposure to 8% O2 had no significant impact on cell viability. Post-hypoxia treatment with moderate hypothermia for 48 or 72 hours rescued the neurons from hypoxia-induced cell death. Moreover, exposure to severe hypoxia led to observable cell swelling, which was also attenuated by moderate hypothermia. Finally, moderate hypothermia but not hypoxia led to the induction of RBM3 expression on both transcriptional and translational levels. Conclusion: Moderate hypothermia protects neurons from hypoxia-induced cell death. The expression of the cold-shock protein RBM3 is induced by moderate hypothermia and could be one possible mediator of hypothermia-induced neuroprotection.Keywords
This publication has 42 references indexed in Scilit:
- Neonatal anoxia in rats: Hippocampal cellular and subcellular changes related to cell death and spatial memoryNeuroscience, 2015
- Effects of moderate and deep hypothermia on RNA-binding proteins RBM3 and CIRP expressions in murine hippocampal brain slicesBrain Research, 2013
- Widespread Regulation of miRNA Biogenesis at the Dicer Step by the Cold-Inducible RNA-Binding Protein, RBM3PLOS ONE, 2011
- The RNA-binding protein RBM3 is involved in hypothermia induced neuroprotectionNeurobiology of Disease, 2011
- Treatment advances in neonatal neuroprotection and neurointensive careThe Lancet Neurology, 2011
- Post-ischemic hypothermia for 24 h in P7 rats rescues hippocampal neuron: Association with decreased astrocyte activation and inflammatory cytokine expressionBrain Research Bulletin, 2009
- Two isoforms of the cold‐inducible mRNA‐binding protein RBM3 localize to dendrites and promote translationJournal of Neurochemistry, 2007
- Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic EncephalopathyNew England Journal of Medicine, 2005
- Evidence against Volume Regulation by Cortical Brain Cells during Acute Osmotic StressExperimental Neurology, 1997
- Quantitative Relationship between Brain Temperature and Energy Utilization Rate Measured in Vivo Using 31P AND 1H Magnetic Resonance SpectroscopyPediatric Research, 1995